compounded tirzepatide fda confirms shortage is still over, gives compounders a grace period Compounded Tirzepatide: Legal & Safe

We recommend you see an in-person provider for your care if: You use tobacco and are 35 years or older You have a history of breast cancer, bariatric surgery, stroke, heart disease, cirrhosis or lupus You are seeking Depo-Provera, Phexxi, temporary menses delay, IUD or Nexplanon

Those are literature ranges across studies rather than a single trial result

GLP-1 RAs have shown a trend toward cardioprotective effects, including reductions in the risk of major cardiovascular eventssuch as stroke, MI, HF, peripheral artery disease, MACE, CVD, and cardiovascular mortality

Your body thinks its starving and attempts to store energy

Cardiovascular benefits associated with some GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) observed in clinical trials are likely to diminish after discontinuation, though the exact persistence of these benefits remains uncertain